только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 6 / 36
Страница 1 / 1

Литература

  1. O’Driscoll M, Ribeiro Dos Santos G, Wang L, et al. Age-specific mortality and immunity patterns of SARSCoV-2. Nature. 2021;590:140-5. doi:10.1038/s41586-020-2918-0.
  2. Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract. 2020;165:108-266. doi:10.1016/j.diabres.2020.108266.
  3. Petrakis D, Margină D, Tsarouhas K, et al. Obesity — a risk factor for increased COVID-19 prevalence, severity and lethality. Mol Med Rep. 2020;22:9-19. doi:10.3892/mmr.2020.11127.
  4. Momtazmanesh S, Shobeiri P, Hanaei S, et al. Cardiovascular disease in COVID-19: A systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J. 2020;72:41. doi:10.1186/s43044-020-00075-z.
  5. Bucciol G, Tangye SG, Meyts I. Coronavirus disease 2019 in patients with inborn errors of immunity: Lessons learned. Curr Opin Pediatr. 2021;33:648-56. doi:10.1097/MOP.0000000000001062.
  6. Shields AM, Burns SO, Savic S, Richter AG. COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience. J Allergy Clin Immunol. 2021;147:870-5.e1. doi:10.1016/j.jaci.2020.12.620.
  7. Zarifkar P, Kamath A, Robinson C, et al. Clinical Characteristics and Outcomes in Patients with COVID19 and Cancer: A Systematic Review and Meta-analysis. Clin Oncol (R Coll Radiol). 2021;33:e180-e191. doi:10.1016/j.clon.2020.11.006.
  8. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: A retrospective, multicentre, cohort study. The Lancet Haematology. 2020;7:e737-e745. doi:10.1016/S2352-3026(20)30251-9.
  9. Dong Y, Li Z, Ding S, et al. HIV infection and risk of COVID-19 mortality: A meta-analysis. Medicine (Baltimore). 2021;100:e26573. doi:10.1097/md.0000000000026573.
  10. Cai R, Zhang J, Zhu Y, et al. Mortality in chronic kidney disease patients with COVID-19: A systematic review and meta-analysis. Int Urol Nephrol. 2021;53:1623-9. doi:10.1007/s11255-020-02740-3.
  11. Philips CA, Kakkar K, Joseph M, et al. Critically Ill COVID-19 Patient with Chronic Liver Disease — Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol. 2021;9:576-86. doi:10.14218/ jcth.2020.00110.
  12. Приказ Министерства здравоохранения Российской Федерации от 04.02.2022 № 57н “О внесении изменений в приказ Министерства здравоохранения Российской Федерации от 19 марта 2020 г. № 198н “О временном порядке организации работы медицинских организаций в целях реализации мер по профилактике и снижению рисков распространения новой коронавирусной инфекции COVID-19”.
  13. Ramzi ZS. Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients; A systematic review and meta-analysis. The American Journal of Emergency Medicine. 2021;51:267-79. doi:10.1016/j.ajem.2021.10.059.